PHARMATECA » Search Articles by Keyword
Found: 12 articles
Article |
Edition |
Zilberberg N.V., Kokhan M.M., Kashcheeva Ya.V.
Hidradenitis suppurativa: on the issue of rational therapy
|
№5 / 2024
|
N.L. Ryabkova, I.M. Marusenko, N.D. Silvestrova, Ya.A. Avdeeva, V.A. Ryabkov
Comorbid infections in patients with rheumatic diseases in the Republic of Karelia: a retrospective analysis (according to the data from Republican Hospital n.a. V.A. Baranov, Petrozavodsk)
|
№9/10 / 2023
|
I.S. Burashnikova
The rationale for the combined use of genetically engineered biological drugs in patients with COVID-19
|
№8 / 2021
|
I.S. Burashnikova
The rationale for re-administration of genetically engineered biological drugs in patients with COVID-19
|
№8 / 2021
|
S.S. Dotsenko, L.N. Shilova
CLINICAL AND LABORATORY PREDICTORS OF EFFECTIVENESS OF BACKGROUND THERAPY IN RHEUMATOID ARTHRITIS
|
№19 / 2017
|
V.V. Ryazhenov (1, 2), S.G. Gorokhov (2, 3), E.R. Volkova (2)
PHARMACOECONOMIC ANALYSIS OF DIFFERENT STRATEGIES OF MONOTHERAPY WITH GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN RUSSIAN PATIENTS WITH RHEUMATOID ARTHRITIS
|
№7 / 2015
|
E.A. Aseeva, M.E. Tsanyan, A.V. Torgashina
PROSPECTS FOR ANTI-B-CELL THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
|
№7 / 2014
|
S.O. Salugina, E.S. Fedorov
MODERN APPROACHES TO TREATMENT OF JUVENILE ARTHRITIS
|
№20 / 2013
|
A.N. Fetisova, E.I. Alexeyeva, MD, T.M. Bzarova, N.I. Taybulatov, A.V. Starikova, A.V. Anikin, G.A. Bekdzhanyan
EXPERIENCE OF USE OF ETANERCEPT IN EARLY JUVENILE ANKYLOSING SPONDYLITIS
|
№7 / 2013
|
N.V. Chichasova
Prevention Of Adverse Outcomes Of Rheumatoid Arthritis: Modern Therapeutic Strategy
|
№6 / 2012
|
D. Karateev
Rituximab In The Current Therapy Of Rheumatoid Arthritis
|
№5 / 2010
|
E.L. Luchihina
Place Of Ciclosporin A In Modern Therapy Of Rheumatoid Arthritis
|
№15 / 2009
|
{"loading":"Loading...","close":"Close","yes":"Yes","no":"No","proceed":"Proceed","conf_del":"Do you really want to delete","cancel":"Cancel"}